These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26378043)

  • 1. Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.
    Zhou X; Ren Y; Kong L; Cai G; Sun S; Song W; Wang Y; Jin R; Qi L; Mei M; Wang X; Kang C; Li M; Zhang L
    Oncotarget; 2015 Oct; 6(32):33720-32. PubMed ID: 26378043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
    Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
    Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
    Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
    Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
    Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
    Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
    Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting HOTAIR Induces Mitochondria Related Apoptosis and Inhibits Tumor Growth in Head and Neck Squamous Cell Carcinoma in vitro and in vivo.
    Kong L; Zhou X; Wu Y; Wang Y; Chen L; Li P; Liu S; Sun S; Ren Y; Mei M; Wang X; Zhang L
    Curr Mol Med; 2015; 15(10):952-60. PubMed ID: 26592246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
    Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
    Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells.
    Lo WL; Chien Y; Chiou GY; Tseng LM; Hsu HS; Chang YL; Lu KH; Chien CS; Wang ML; Chen YW; Huang PI; Hu FW; Yu CC; Chu PY; Chiou SH
    Biomaterials; 2012 May; 33(14):3693-709. PubMed ID: 22361100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation.
    Mochizuki D; Misawa Y; Kawasaki H; Imai A; Endo S; Mima M; Yamada S; Nakagawa T; Kanazawa T; Misawa K
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
    Cheng Y; Song Z; Fang X; Tang Z
    Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
    Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
    Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma.
    Wang Z; Chen J; Zhang W; Zheng Y; Wang Z; Liu L; Wu H; Ye J; Zhang W; Qi B; Wu Y; Song X
    Oncotarget; 2016 Feb; 7(5):6048-62. PubMed ID: 26755661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
    PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rap1 and its regulatory proteins: the tumor suppressor, oncogene, tumor suppressor gene axis in head and neck cancer.
    Banerjee R; Russo N; Liu M; Van Tubergen E; D'Silva NJ
    Small GTPases; 2012; 3(3):192-7. PubMed ID: 22684501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.
    Özeş AR; Pulliam N; Ertosun MG; Yılmaz Ö; Tang J; Çopuroğlu E; Matei D; Özeş ON; Nephew KP
    Oncogene; 2018 Jun; 37(26):3589-3600. PubMed ID: 29576612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.
    Zhou L; Mudianto T; Ma X; Riley R; Uppaluri R
    Clin Cancer Res; 2020 Jan; 26(1):290-300. PubMed ID: 31562203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
    Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
    Jin Y; Qin X
    DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).
    Zhang J; Wang Y; Chen X; Zhou Y; Jiang F; Chen J; Wang L; Zhang WF
    Oncotarget; 2015 Apr; 6(10):7454-69. PubMed ID: 25762634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 overexpression in head and neck cancer is related to lymph node metastasis.
    Nienstedt JC; Schroeder C; Clauditz T; Simon R; Sauter G; Muenscher A; Blessmann M; Hanken H; Pflug C
    J Oral Pathol Med; 2018 Mar; 47(3):240-245. PubMed ID: 29285811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.